Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135000) titled 'Effect of Tegilidine Fumarate on Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Cholecystectomy: A Prospective, Double-Blind, Randomized Controlled Trial' on Oct. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Hospital of Hebei Medical University
Condition:
Cholecystitis
Cholecystolithiasis
Intervention:
Tegileridine group (Group T):Administer tegulilidine 0.0125 mg/kg by IV injection, flurbiprofen ester 50 mg. PCIA formula: tegulilidine 3.75 mg, flurbiprofen ester 200 mg, total of 50 ml saline. PCIA settings: 4 ml per dose, continuous rate 0.5...